Relationship Between Methylation and Colonic Inflammation in Inflammatory Bowel Disease

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2014 Aug 19

PMID 25132780

Citations 3

Authors

Triana Lobaton

Daniel Azuara

Francisco Rodriguez-Moranta

Carolina Loayza

Xavier Sanjuan

Javier de Oca

Ana Fernandez-Robles

Jordi Guardiola

Gabriel Capella

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate the relationship between the methylation status in the SLIT2 and TGFB2 promoters and colonic inflammation in inflammatory bowel disease patients.

Methods: We evaluated the methylation status of 2 genes (SLIT2 and TGFB2) in 226 biopsies taken from 62 colonoscopies of 38 patients (29 ulcerative colitis and 9 Crohn's colitis) using methylation-specific melting curve analysis. The relationships between methylation status and clinical, biological, endoscopic and histological activities were evaluated. Twenty-three of the 38 patients had a second colonoscopy and were included in a longitudinal analysis. Numerical results were given as the means ± SD of the sample and range, except when specified. Student t analysis, U Mann Whitney and ANOVA factor were used to compare the means. Qualitative results were based on the χ(2) test.

Results: SLIT2 methylation was more frequent in samples with endoscopic activity than with endoscopic remission (55% vs 18%, P < 0.001). SLIT2 methylation was also higher in samples with acute inflammation (56.5%) than in samples with chronic (24%) or absent inflammation (15%) (P < 0.001). For TGFB2 methylation, the correlation was only significant with endoscopic activity. Methylation was higher in the distal colon for both genes (P < 0.001 for SLIT2 and P = 0.022 for TGFB2). In the multivariate analysis, only inflammation status (and not disease duration or extension) was independently associated with SLIT2 methylation [OR = 6.6 (95%CI: 1.65-27.36), P = 0.009]. In the longitudinal analysis, the maintenance of endoscopic remission was protective for methylation.

Conclusion: Endoscopic and histological inflammation are predictive for SLIT2 methylation.

Citing Articles

Epigenetic Regulation of Glycosylation in Cancer and Other Diseases.

Indellicato R, Trinchera M Int J Mol Sci. 2021; 22(6).

PMID: 33804149 PMC: 7999748. DOI: 10.3390/ijms22062980.

From Genetics to Epigenetics, Roles of Epigenetics in Inflammatory Bowel Disease.

Zeng Z, Mukherjee A, Zhang H Front Genet. 2019; 10:1017.

PMID: 31737035 PMC: 6834788. DOI: 10.3389/fgene.2019.01017.

Lung Tumorigenesis Alters the Expression of Slit2-exon15 Splicing Variants in Tumor Microenvironment.

Wu M, Chuang C, Lin P, Chen W, Su S, Liao C Cancers (Basel). 2019; 11(2).

PMID: 30717252 PMC: 6406468. DOI: 10.3390/cancers11020166.

References

Feagins L, Souza R, Spechler S . Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol. 2009; 6(5):297-305. DOI: 10.1038/nrgastro.2009.44. View

Hartnett L, Egan L . Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis. 2012; 33(4):723-31. DOI: 10.1093/carcin/bgs006. View

Herrinton L, Liu L, Levin T, Allison J, Lewis J, Velayos F . Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012; 143(2):382-9. DOI: 10.1053/j.gastro.2012.04.054. View

Konishi K, Shen L, Wang S, Meltzer S, Harpaz N, Issa J . Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. Gastroenterology. 2007; 132(4):1254-60. DOI: 10.1053/j.gastro.2007.01.035. View

DHaens G, Sandborn W, Feagan B, Geboes K, Hanauer S, Irvine E . A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007; 132(2):763-86. DOI: 10.1053/j.gastro.2006.12.038. View

Katsurano M, Niwa T, Yasui Y, Shigematsu Y, Yamashita S, Takeshima H . Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction. Oncogene. 2011; 31(3):342-51. DOI: 10.1038/onc.2011.241. View

Puig P, Urgell E, Capella G, Sancho F, Pujol J, Boadas J . A highly sensitive method for K-ras mutation detection is useful in diagnosis of gastrointestinal cancer. Int J Cancer. 1999; 85(1):73-7. DOI: 10.1002/(sici)1097-0215(20000101)85:1<73::aid-ijc13>3.0.co;2-#. View

Alvarez H, Opalinska J, Zhou L, Sohal D, Fazzari M, Yu Y . Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet. 2011; 7(3):e1001356. PMC: 3069107. DOI: 10.1371/journal.pgen.1001356. View

Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J . Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clin Colorectal Cancer. 2010; 9(3):168-76. DOI: 10.3816/CCC.2010.n.023. View

10.

Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M . Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004; 126(2):451-9. DOI: 10.1053/j.gastro.2003.11.010. View

11.

Goldstone R, Itzkowitz S, Harpaz N, Ullman T . Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance. Inflamm Bowel Dis. 2011; 18(5):832-7. DOI: 10.1002/ibd.21809. View

12.

Sanchez J, Dejulius K, Bronner M, Church J, Kalady M . Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Inflamm Bowel Dis. 2011; 17(9):1966-70. DOI: 10.1002/ibd.21526. View

13.

Goldstone R, Itzkowitz S, Harpaz N, Ullman T . Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location. Gastrointest Endosc. 2011; 74(5):1087-93. DOI: 10.1016/j.gie.2011.06.028. View

14.

Lobaton T, Rodriguez-Moranta F, Lopez A, Sanchez E, Rodriguez-Alonso L, Guardiola J . A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis. Inflamm Bowel Dis. 2013; 19(5):1034-42. DOI: 10.1097/MIB.0b013e3182802b6e. View

15.

Powell-Tuck J, Day D, Buckell N, Wadsworth J, Lennard-Jones J . Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci. 1982; 27(6):533-7. DOI: 10.1007/BF01296733. View

16.

Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K . Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012; 6(10):965-90. DOI: 10.1016/j.crohns.2012.09.003. View

17.

Puig P, Urgell E, Capella G, Villanueva A, Grau M, Sancho F . Improved detection of K-ras codon 12 mutations in fecal exfoliated cells. Lab Invest. 1999; 79(5):617-8. View

18.

Itzkowitz S, Yio X . Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004; 287(1):G7-17. DOI: 10.1152/ajpgi.00079.2004. View

19.

Saito S, Kato J, Hiraoka S, Horii J, Suzuki H, Higashi R . DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status. Inflamm Bowel Dis. 2011; 17(9):1955-65. DOI: 10.1002/ibd.21573. View

20.

Gupta R, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A . Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007; 133(4):1099-105. PMC: 2175077. DOI: 10.1053/j.gastro.2007.08.001. View